Postscript

2021 ◽  
pp. 411-422
Keyword(s):  
Medical Devices ◽  
Large Scale ◽  
Regulatory Framework ◽  
World Health ◽  
Joint Work ◽  
Infected Blood ◽  
Safety Review ◽  
The World ◽  
Health Organization ◽  
The Uk

This chapter reveals some of the major changes in the European and UK regulatory framework following the UK leaving the EU (Brexit), public health consequences of the supply of infected blood products, and the Covid-19 pandemic. It covers issues that occurred after Brexit, the independent medicines and medical devices safety review, and the UK blood enquiry. It also mentions the Medicines and Healthcare products Regulatory Agency (MHRA) that became the UK’s standalone regulator of medicines and medical devices since 1 January 2021, acting independently in joint work with other international regulators. The chapter elaborates on the UK’s intention to develop a new regulatory framework for medical devices that reflect the Independent Medicines and Medical Devices Safety Review published in July 2020. It highlights the European Medicines Agency’s (EMA) cooperation with the World Health Organization (WHO) on developing potential Covid-19 treatments by facilitating large-scale clinical trials.

Marketing matters

2020 ◽  
Vol 8 (7) ◽  
pp. 280-280
Author(s):  
Ruth Oshikanlu
Keyword(s):  
World Health Organization ◽  
World Health ◽  
Health Visitors ◽  
The World ◽  
Health Organization ◽  
The Uk

When 2020 was declared by the World Health Organization as the International Year of the Nurse and Midwife, health visitors in the UK planned events to celebrate nursing. How can we raise the profile of our honourable profession more effectively?

Have interventions been effective at increasing the rates of breastfeeding in the UK?

2019 ◽  
Vol 27 (5) ◽  
pp. 312-319
Author(s):  
Elizabeth Shortis
Keyword(s):  
World Health Organization ◽  
Exclusive Breastfeeding ◽  
Literature Search ◽  
World Health ◽  
Exclusion Criteria ◽  
The World ◽  
Breastfeeding Rates ◽  
Health Organization ◽  
The Uk ◽  
Combined Interventions

Background The World Health Organization recommends exclusive breastfeeding for the first 6 months of life; however, UK breastfeeding rates are some of the lowest worldwide. As such, various interventions have been trialled, aiming to increase breastfeeding rates. Aims To evaluate the effectiveness of interventions to increase breastfeeding rates in the UK and determine the features of successful interventions. Methods A literature search was performed, using four databases. The results were refined by applying inclusion and exclusion criteria. Two additional articles were recognised by scanning the references sections of identified studies, resulting in 12 articles for review. Findings Support-based interventions had predominantly insignificant effects upon breastfeeding rates. Incentives were associated with increases in rates, while combined interventions had mixed success. The interventions were well received by mothers and clinicians and may help to normalise breastfeeding. Conclusions Future interventions should provide targeted, personalised support to overcome breastfeeding difficulties, and reward mothers for their efforts.

scholarly journals The prevalence of dental erosion in 5-year-old preschoolers in Sharjah, United Arab Emirates

2016 ◽  
Vol 10 (02) ◽  
pp. 215-219 ◽  
Author(s):  
Vellore Kannan Gopinath
Keyword(s):  
United Arab Emirates ◽  
Dental Health ◽  
Dental Erosion ◽  
World Health ◽  
Caries Experience ◽  
Tooth Erosion ◽  
The World ◽  
Erosion Index ◽  
Health Organization ◽  
The Uk

ABSTRACT Objective: The aim of this study was to determine the percentage of 5-year-old preschoolers in Sharjah, affected by dental erosion and to assess the predictors. Materials and Methods: A total of 403 5-year-old children were examined of which 48.14% (n = 194) were boys and 51.86% (n = 209) were girls; 31.27% (n = 126) were Emirati and 68.73% (n = 277) were non-Emirati Arabs. Examination of dental erosion was confined to palatal surfaces of maxillary incisors using the erosion index described in the UK National Survey of Children's Dental Health, 1993. Dental caries was charted using the World Health Organization 1997 criteria. Results: In the sample of 403 5-year-old preschoolers examined, dental erosion was apparent in 237 (58.80%) children, with 55.09% showing the dissolution of enamel and 3.72% exhibiting exposed dentin. Predictors of dental erosion as determined by logistic regression concluded that compared to Emirati citizens other Arab nationalities have 0.27 times the odds (95% confidence interval [CI] =0.18–0.42) of having tooth erosion (P < 0.05). Children with caries experience have 0.28 times the odds (95% CI = 0.16–0.51) of having tooth erosion compared to children with no caries experience (P < 0.05). Children who drink sugary or carbonated beverages have 0.30 times the odds (95% CI = 0.19–0.41) of having dental erosion compared to children who drink water (P < 0.05). Conclusions: The findings of this study indicate that 58.80% of 5-year-old preschoolers in Sharjah, United Arab Emirates, were affected by dental erosion. Caries experience and consumption of acidic drinks were associated with dental erosion.

scholarly journals Outbreak column 21: Tuberculosis (TB): Still a nosocomial threat

2017 ◽  
Vol 19 (3) ◽  
pp. 144-150
Author(s):  
Evonne T Curran
Keyword(s):  
Disease Control ◽  
World Health Organization ◽  
Infection Prevention ◽  
World Health ◽  
Nosocomial Transmission ◽  
National Guidance ◽  
The World ◽  
Control And Prevention ◽  
Health Organization ◽  
The Uk

This outbreak column explores the epidemiology and infection prevention guidance on tuberculosis (TB) in the UK. The column finds that, at present, national guidance leaves UK hospitals ill-prepared to prevent nosocomial TB transmission. Reasons for this conclusion are as follows: (1) while TB is predominantly a disease that affects people with ‘social ills’, it has the potential to infect anyone who is sufficiently exposed; (2) nosocomial transmission is documented throughout history; (3) future nosocomial exposures may involve less treatable disease; and (4) current UK guidance is insufficient to prevent nosocomial transmission and is less than that advocated by the World Health Organization and the Centers for Disease Control and Prevention.

scholarly journals Epidemiological Models of SARS-CoV-2 (COVID-19) to Control the Transmission Based on Current Evidence: A Systematic Review

2020 ◽  
Author(s):  
Swati Arora ◽  
Rishabh Jain ◽  
Harendra Pal Singh
Keyword(s):  
Real Data ◽  
World Health ◽  
Current Evidence ◽  
Epidemiological Models ◽  
Medical Supplies ◽  
The World ◽  
The Usa ◽  
Novel Coronavirus ◽  
Health Organization ◽  
The Uk

In Wuhan city of China, an episode of novel coronavirus (COVID-19) happened. during late December and it has quickly spread to all places in the world. Until May 29, 2020, cases were high in the USA with 1.7 Million, Russia with approximately 387 thousand, the UK with 271 thousand confirmed cases. Everybody on the planet is anxious to know when the coronavirus pandemic will end. In this scourge, most nations force extreme medication measures to contain the spread of COVID-19. Modeling has been utilized broadly by every national government and the World Health Organization in choosing the best procedures to seek after in relieving the impacts of COVID-19. Many epidemiological models are studied to understand the spread of the illness and its prediction to find maximum capacity for human-to-human transmission so that control techniques can be adopted. Also, arrangements for the medical facilities required such as hospital beds and medical supplies can be made in advance. Many models are used to anticipate the results keeping in view the present scenario. There is an urgent need to study the various models and their impacts. In this study, we present a systematic literature review on epidemiological models for the outbreak of novel coronavirus in India. The epidemiological dynamics of COVID-19 is also studied. Here, In addition, an attempt to take out the results from the exploration and comparing it with the real data. The study helps to choose the models that are progressive and dependable to predict and give legitimate methods for various strategies.

scholarly journals United Kingdom–East and Southern Africa Partnership at the Forefront of Developing the First Ever Test that Measures Patient Tuberculosis Burden in Hours

2019 ◽  
Vol 1 (1) ◽  
pp. 3-8
Author(s):  
Wilber Sabiiti
Keyword(s):  
Clinical Trials ◽  
Mycobacterium Tuberculosis ◽  
Southern Africa ◽  
Patient Management ◽  
Bacterial Load ◽  
World Health ◽  
Great Opportunity ◽  
The World ◽  
Health Organization ◽  
The Uk

  Mycobacterium tuberculosis has caused tuberculosis (TB) in humans for at least 3 millennia, but the disease has evaded eradication efforts by all human civilisations despite promising technological advancements. The World Health Organization (WHO) has set a target of ending the TB epidemic by 2035. Going by the current rate of progress, it is estimated that it will take another 160 years to realise the WHO End TB Strategy’s target. Accelerating the eradication of TB will require effective tools for diagnosis, vaccines and medicines to treat the disease, and efficient implementation thereof. This presents a great opportunity for innovators in East Africa and the world over to chip in and develop the best technologies to end TB. With funding from the European and Developing Countries Clinical Trials Partnership (EDCTP), partnerships between the UK-based University of St Andrews and research institutions in East and Southern Africa have led to the development of the first ever test – the molecular bacterial load assay (MBLA) – that measures the number of TB bacteria in a patient and reveals if this number is declining as a patient progresses on treatment. Initial assay results are available within 4 hours. Real-time knowledge of patient mycobacterial burden and the effectiveness of prescribed medications are crucial for timely clinical decisions on patient management.

scholarly journals United Kingdom–East and Southern Africa Partnership at the Forefront of Developing the First Ever Test that Measures Patient Tuberculosis Burden in Hours

2019 ◽  
Vol 1 (1) ◽  
pp. 3-8
Author(s):  
Wilber Sabiiti
Keyword(s):  
Clinical Trials ◽  
Mycobacterium Tuberculosis ◽  
Southern Africa ◽  
Patient Management ◽  
Bacterial Load ◽  
World Health ◽  
Great Opportunity ◽  
The World ◽  
Health Organization ◽  
The Uk

  Mycobacterium tuberculosis has caused tuberculosis (TB) in humans for at least 3 millennia, but the disease has evaded eradication efforts by all human civilisations despite promising technological advancements. The World Health Organization (WHO) has set a target of ending the TB epidemic by 2035. Going by the current rate of progress, it is estimated that it will take another 160 years to realise the WHO End TB Strategy’s target. Accelerating the eradication of TB will require effective tools for diagnosis, vaccines and medicines to treat the disease, and efficient implementation thereof. This presents a great opportunity for innovators in East Africa and the world over to chip in and develop the best technologies to end TB. With funding from the European and Developing Countries Clinical Trials Partnership (EDCTP), partnerships between the UK-based University of St Andrews and research institutions in East and Southern Africa have led to the development of the first ever test – the molecular bacterial load assay (MBLA) – that measures the number of TB bacteria in a patient and reveals if this number is declining as a patient progresses on treatment. Initial assay results are available within 4 hours. Real-time knowledge of patient mycobacterial burden and the effectiveness of prescribed medications are crucial for timely clinical decisions on patient management.

Following the directives of World Health Organization: A Hobsons Choice

Coronaviruses ◽  
2020 ◽  
Vol 01 ◽  
Author(s):  
Shaima S. Ali Miraj
Keyword(s):  
World Health Organization ◽  
Large Scale ◽  
Financial Burden ◽  
International Health ◽  
Health Agency ◽  
Developed Countries ◽  
World Health ◽  
Effective Control ◽  
The World ◽  
Health Organization

Introduction: Of late several articles in prestigious scientific platforms have shown that, 'COVID-19 has questioned the global health expertise of some developed countries like the USA UK and other European nations as well as the international health agency, the World Health Organization, highlighting that they faltered in managing the crisis during the pandemic. The objective of this article is to highlight the fact that as there was no specific vaccine or treatment at hand, the portfolio available with these nations under the directions of the WHO to counter the measures against COVID19, was limited. There was no other alternative in this time of world’s most unprecedented emergency, and whatever immediate steps were taken to contain the virus spread by the WHO were justified. Methods: Using the available literature on the internet and library sources, a survey of published articles in leading journals of the world have been made to analyse the various articles describing the position of the WHO and its future strategies in dealing with the worlds most unprecedented pandemic. Results and Conclusion: The present communication suggests that a large scale fund allocation in a fixed percentage for Health for All, from every member country’s defence budget can be separately made for substantially replenishing the already depleting funding of the WHO. This will enable an effective control of the global pandemic crisis with significant international cooperation, allowing sharing of the financial burden. The specially created fund can be used under international monitoring for such unprecedented calamities in future. More focus can thus be given to special training of manpower, advancements in the protective equipment, development of vaccines, critical care hospitals and centres on a global basis.

Converting to a Synchronous Virtual Nursing Research Conference Amidst a Pandemic: A Case Study

2021 ◽  
Vol 27 (2) ◽  
pp. 118-124
Author(s):  
Lilian J. Canamo ◽  
Jessica P. Bejar ◽  
Judy E. Davidson
Keyword(s):  
World Health Organization ◽  
Large Scale ◽  
University Of California ◽  
World Health ◽  
User Engagement ◽  
Research Conference ◽  
The World ◽  
Health Organization ◽  
The University

University of California San Diego Health was set to launch its 13th annual Nursing and Inquiry Innovation Conference event in June 2020. However, the Coronavirus Disease 2019 (COVID-19) pandemic placed a barrier to large gatherings throughout the world. Because the World Health Organization designated 2020 as the Year of the Nurse and Midwife, the University committed to continuing the large-scale conference, converting to a virtual event. This article reviews the methodologies behind the delivery of the virtual event and implications for user engagement and learning on the blended electronic platform.

Sign in / Sign up

Export Citation Format

Share Document